Eagle Global Advisors LLC Compugen LTD Transaction History

Eagle Global Advisors LLC

  • $1.96 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.8 - $8.02 $226,200 - $312,780
-39,000 Closed
0 $0
Q1 2021

May 07, 2021
SELL
$7.67 - $13.77 $69,030 - $123,930
-9,000 Reduced 18.75%
39,000 $335,000
Q4 2020

Feb 01, 2021
BUY
$12.07 - $17.95 $205,190 - $305,150
17,000 Added 54.84%
48,000 $581,000
Q3 2020

Oct 22, 2020
BUY
$14.16 - $19.45 $283,200 - $389,000
20,000 Added 181.82%
31,000 $504,000
Q2 2020

Aug 14, 2020
BUY
$6.97 - $17.12 $76,670 - $188,320
11,000 New
11,000 $165,000

Others Institutions Holding CGEN

# of Institutions
73
Shares Held
13.1M
Call Options Held
79.2K
Put Options Held
12.7K
View Full List

About COMPUGEN LTD

CGEN Quotes by TradingView
  • Ticker CGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 86,624,600
  • Market Cap $131M
  • Description
  • Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...
More about CGEN
Track This Portfolio

Track Eagle Global Advisors LLC Portfolio

Follow Eagle Global Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Global Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Global Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email